PTEN, also known as MMAC1 or TEP1, is a tumor suppressor gene inactivated in many common malignancies, including glioblastoma, melanoma, endometrial, lung, and prostate cancer (1) (2) (3) (4) (5) . The genetic evidence that PTEN is an important tumor suppressor protein is supported by the fact that heterozygous disruption of the PTEN gene in knockout mice results in the spontaneous development of tumors late in life (6) . PTEN has been implicated in regulating cell survival signaling through the phosphatidylinositol 3-kinase (PI3K) 1 /Akt pathway. PTEN dephosphorylates the D3 position of the key lipid second messenger phosphatidylinositol 3,4,5-triphosphate (PIP 3 ) (6 -8) . PIP 3 , produced by PI3K following activation by receptor tyrosine kinases, activated Ras, or G proteins, leads to the stimulation of several downstream targets, including the serine/threonine protein kinase Akt (also known as protein kinase B) (1) (2) (3) (4) (5) . Activated Akt protects cells from apoptotic death by phosphorylating substrates such as BAD, procaspase-9, and forkhead transcription family members (9 -11) . Akt has also been shown to prolong cell survival by delaying p53-dependent apoptosis (12) . Recently, Akt has been proposed to regulate permeability transition pore opening within the mitochondrial membrane by increasing the coupling of glucose metabolism to oxidative phosphorylation (13) . Finally, multiple laboratories have demonstrated that the PI3K/Akt pathway provides cell survival signals, in part, through the activation of the NF-B transcription factor (14 -17) .
NF-B, classically a heterodimer composed of the p50 and p65 subunits, is a transcription factor whose activity is tightly regulated at multiple levels (18 -21) . NF-B is normally sequestered in the cytoplasm as an inactive complex bound by an inhibitor known as IB (18) . Following cellular stimulation, IB proteins become phosphorylated by the IB kinase (IKK), which subsequently targets IB for ubiquitination and degradation through the 26 S proteasome (20) . The degradation of IB proteins liberates NF-B, allowing this transcription factor to translocate to the nucleus. In addition to regulation by IB, NF-B is also regulated by phosphorylation events that positively up-regulate the transactivation potential of NF-B subunits (22) . The transactivation domains of NF-B have been shown to be regulated by the catalytic domain of protein kinase A, casein kinase II, and by IKK itself (23) (24) (25) (26) (27) . Although signals that regulate nuclear translocation of NF-B have been regarded as the primary mechanism of NF-B activation, alternative mechanisms involving the transactivation potential of p65 have been shown to be critical for NF-B activation in vitro and in vivo (22, 28, 29) .
Several different laboratories, including our own, have shown that various growth factors, cytokines, and oncogenes require PI3K-and Akt-dependent pathways for full NF-B activation (30 -36) . Despite this consensus, the exact mechanism by which Akt pathways activate NF-B remains controversial (37) . Activation of the Akt pathway has been reported to stimulate IKK-dependent IB degradation and nuclear translocation of NF-B (14, 31) . Other reports including our own (15, 30, 36) have shown that Akt-dependent activation of NF-B occurs predominantly by stimulating the transactivation potential of the p65 subunit, rather than inducing signals that result in NF-B nuclear translocation via IB degradation. Recently, two reports (38, 39) from independent laboratories analyzed the effects of PTEN-dependent inhibition of the PI3K and Akt pathway on cytokine-induced activation of NF-B. Both reports concluded that PTEN expression blocked IL-1␤ or TNF-induced NF-B activation; however, major discrepancies exist between these two studies. Koul et al. (38) showed that PTEN-dependent inhibition of Akt failed to block IL-1␤-induced IB degradation and nuclear translocation of p65 but rather inhibited NF-B-DNA binding. In this study, it was proposed that PTEN functioned to inhibit phosphorylation of the p50 subunit of NF-B, thus inhibiting the DNA binding potential of NF-B (38) . In contrast, Gustin et al. (39) reported that PTEN inhibited NF-B transcriptional activity by impairing TNF-induced activation of Akt and the IKK complex, suggesting that the PTEN-mediated inhibition of IKK activity blocked the TNF-induced nuclear translocation and DNA binding potential of NF-B. Although both of these studies (38, 39) demonstrate that PTEN is capable of inhibiting cytokine-induced activation of NF-B, it remains ambiguous as to whether PTEN-dependent inhibition of Akt inhibits NF-B by downregulating signals that control nuclear translocation, DNA binding, and/or transactivation potential of NF-B.
To address the involvement of PI3K and Akt in TNF-induced activation of NF-B, we utilized PTEN-deficient prostate cell lines that constitutively express activated Akt because of a loss of PTEN lipid phosphatase activity (40, 41) . In this study, we demonstrate that re-introduction of PTEN into prostate cells results in a down-regulation of Akt activity and a loss of TNFinduced NF-B-dependent transcription without blocking IKKinduced IB degradation, p105 processing, p65 nuclear translocation, or NF-B DNA binding activity. However, we find that neither Akt nor IKK is dispensable for TNF to stimulate the transactivation potential of the p65 subunit of NF-B in prostate epithelial cells. We demonstrate that PTEN elicits selective inhibition by blocking signal transduction pathways that are responsible for targeting the transactivation potential of NF-B and CREB but not for c-Jun. The ability of PTEN to inhibit Akt activity and subsequently block TNF-induced transcriptional activity of NF-B led to abrogation of the antiapoptotic function of NF-B. This work demonstrates that reintroduction of PTEN sensitizes prostate epithelial cells to TNF-induced apoptosis, in part by down-regulating the transactivation potential of NF-B. Thus, NF-B is a relevant target of the tumor suppressor function of PTEN.
MATERIALS AND METHODS
Cell Culture, Reagents, and Plasmid Constructs-Human prostate cancer cells, LNCaP, were grown in T-media (Invitrogen) supplemented with 10% fetal calf serum (HyClone Laboratories, Logan, UT) and penicillin/streptomycin. PC-3 and DU-145 cells were cultured in Dulbecco's modified Eagle's medium-H (Invitrogen) supplemented with 10% fetal bovine serum and penicillin/streptomycin. The 3ϫ-B luciferase (3ϫ-B-Luc) reporter construct contains four NF-B DNA-binding consensus sites originally identified in the MHC class I promoter, fused upstream to firefly luciferase (42) . The Gal-4 luciferase construct (Gal4-Luc) contains four Gal-4 DNA-binding consensus sites, derived from the yeast GAL-4 gene promoter, cloned upstream of luciferase cDNA (42) . Plasmids encoding the Gal4-p65 fusion protein have the yeast Gal-4 DNA binding domain fused to the transactivation domain 1 (TA1) of NF-B (43). Gal4-cJun-(1-223) and Gal4-CREB-(1-283) were commercially purchased (Stratagene, La Jolla, CA). His-tagged ␤-galactosidase encoding plasmid pCMV-LacZ was obtained from Invitrogen. Expression plasmids encoding constitutively activated HaRas(V12), PI3K*, myristoylated Akt (M-Akt), and wild-type IKK␤ (wtIKK␤) and plasmids encoding dominant negative PI3K (p85), Akt(K-M), and IKK␤(SS Ͼ Ͼ AA) proteins have been described previously (15) . Plasmids encoding constitutively active FLAG-tagged CaMKKc were described previously (44) . The expression vectors pcDNA3-PTENwt and pcDNA3-PTEN C124S have been described previously (41) . The PTEN G129E mutant was constructed using the Quikchange site-directed mutagenesis kit (Stratagene) and verified by DNA sequence analysis. Recombinant human TNF was obtained from Promega (Madison, WI). PTEN (N19), His epitope tag (G-18), IB␣ (C-21), p50 (N19), and Gal-4 (N19) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Pan-Ras antibody (Ab-4) was purchased from Calbiochem. Phospho-Akt-specific (Ser-473), pan-Akt, and IKK␥ antibodies were obtained from New England Biolabs (Beverly, MA). p65-specific antibody was obtained through Rockland (Gilbertsville, PA), and M2 FLAG epitope tag and ␣-tubulin (T9026) were obtained from Sigma. The proteasome inhibitor MG132 (C2211) was obtained from Sigma.
Transfection and Luciferase Reporter Assays-LNCaP cells at 60 -80% confluency were transiently transfected using Superfect reagent (Qiagen, Valencia, CA) according to the manufacturer's instructions. Briefly, plasmid constructs (1 g of DNA total) were diluted in serumfree media and mixed with the Superfect reagent. Complexes were allowed to form for 10 min before serum-containing media were added to the mixture. The cells were washed once with 1ϫ phosphate-buffered saline, and Superfect-DNA complexes were added to the cells and placed in a humidified incubator at 37°C with 5% CO 2 . Three hours following the start of transfection, cells were washed with 1ϫ phosphate-buffered saline and replenished with fresh serum-containing media. Twenty four hours post-transfection, cells were washed once with 1ϫ phosphate-buffered saline and lysed in 0.25 M Tris-HCl (pH 7.4) following three freeze-thaws in a dry-ice/ETOH bath. Extracts were collected and cleared by centrifugation at 14,000 rpm. Protein concentrations were determined with the Bio-Rad protein assay dye reagent. Luciferase assays were performed on equal amounts of protein (100 g/sample). D-Luciferin was used as a substrate, and relative light units were measured using an AutoLumat LB953 luminometer (Berthold Analytical Instruments). For control purposes, all cell groups that received PTEN were also co-transfected with pCMV-LacZ and assayed for transfection efficiency by counting ␤-galactosidase-positive cells as described previously (45) .
Adenovirus Construction and Infection-Ad-PTEN is a replicationdefective E1-deleted adenovirus expressing PTEN under the control of the cytomegalovirus promoter. Recombinant PTEN adenovirus was constructed as described previously (46) . Recombinant virus was plaque-purified three times, and the structure was verified by restriction mapping of Hirt supernatant DNA. Ad-GFP, similarly constructed, expresses enhanced green fluorescent protein and was provided by Dr. Lily Wu (UCLA). Adenovirus was amplified in 293 cells and purified by banding in a cesium chloride density gradient.
Electrophoretic Mobility Shift Assays and Western Blot AnalysisPreparation of nuclear and cytoplasmic extracts and electrophoretic mobility shift assays (EMSAs) were performed as described previously (42) . Briefly, nuclear extracts were prepared at the indicated times and incubated with [ 32 P]dCTP-labeled, double-stranded probe containing an NF-B consensus site from the class I major histocompatibility complex (MHC) promoter. Labeled probe-nuclear complexes were incubated for 10 min at room temperature and separated on a 5% polyacrylamide gel. Subsequently, the gel was dried and exposed to x-ray film. Western blot analysis was performed by either analyzing 0.25 M Tris-HCl-lysed cell extracts or cytoplasmic and nuclear proteins on a 10% SDS-polyacrylamide gel. Total protein (50 g) was separated by SDS-PAGE and transferred to nitrocellulose membranes. The indicated primary antibodies were incubated for 30 min, washed, and visualized by incubation IKK Immunokinase Assay-Subconfluent LNCaP cells infected with either Ad-GFP or Ad-PTEN for 48 h were either left untreated or were stimulated with 10 ng/ml TNF for 15 min. Whole cells extracts were immunoprecipitated with an antibody against IKK␥ (New England Biolabs), and the immunoprecipitates were subject to an IKK assay (26) using GST-IB␣-(1-54) (4 g) as a substrate. Samples were resolved on SDS-PAGE gels, dried, and subjected to autoradiography. Immunoprecipitated protein complexes were also analyzed by Western blot analysis to confirm that equal amounts of IKK␥ had been analyzed during the IKK assay. Whole cell lysates were analyzed by Western blot analysis for PTEN expression.
Northern Blot Analysis-Logarithmically growing LNCaP cells were infected with either Ad-GFP or Ad-PTEN virus. Twenty four hours later, cells were either left untreated (t 0 ) or stimulated with TNF (10 ng/ml). Total RNAs were isolated using Trizol reagent (Invitrogen). RNAs (15 g/lane) were resolved on a denaturing 1.8% agarose-formaldehyde gel, transferred to Hybond membrane (PerkinElmer Life Sciences), and crossed-linked. Gene expressions were determined by analyzing Northern blots with 32 P-labeled random probes generated from NF-B1, bcl-3, or GAPDH cDNAs, and blots were hybridized with radiolabeled probes in Quickhyb (Stratagene). After a 2-h hybridization, the blots were washed twice in 2ϫ SSC, 0.1% SDS for 15 min at room temperature and twice in 0.1ϫ SSC, 0.1% SDS for 15 min at 60°C. Northern blots were analyzed by autoradiography.
Apoptosis Assay-LNCaP cells were plated at 5 ϫ 10 5 cells per well in a 6-well plate on day 0 and infected with adenovirus at 10 pfu/cell on day 1. TNF was added to the media on day 2. After 24 h of incubation with TNF, cells were harvested, and the extent of apoptosis was determined by quantitation of nucleosomes released into the cytoplasm using the Cell Death Detection ELISA Plus kit (Roche Molecular Biochemicals) according to the manufacturer's directions. (15, 36) that PI3K and Akt activate NF-B predominantly by targeting the transactivation potential of the p65 subunit. Because PTEN is the predominant negative regulator of Akt in vitro and in vivo (1-6), we were interested in determining whether the PTEN tumor suppressor gene product could inhibit NF-B transcriptional activity. To address this question we used the human prostate cell line LNCaP, in which endogenous Akt is constitutively active due to inactivation of PTEN (40, 41) . LNCaP cells were transiently co-transfected with the NF-Bresponsive reporter 3ϫ-B-Luc and with wild-type PTEN or various PTEN mutants. Functionally inactive mutants included PTEN(C124S), which is defective in both protein and lipid phosphatase activity, and PTEN(G129E), which is selectively deficient in lipid phosphatase activity (7, 47) . Following transfection, LNCaP cells were subsequently treated with TNF for 12 h, after which cell extracts were harvested and luciferase activities were analyzed. Cells transfected with an expression plasmid encoding wild-type PTEN displayed a reduction in TNF-induced NF-B-dependent transcription, as compared with cells transfected with the empty vector control (Fig. 1A) . The decrease in 3ϫ-B luciferase reporter activities observed following the expression of PTEN was not due to cell death, because an internal ␤-galactosidase reporter displayed similar levels of protein expression 12 h post-TNF addition (Fig. 1A) . Importantly, the ability of PTEN to suppress NF-B-dependent transcriptional activity was associated with the lipid phosphatase activity of this tumor suppressor gene product, because both PTEN(C124S) and PTEN(G129E) mutants were unable to block effectively the TNF-induced NF-B transcriptional activity (Fig. 1A) . In conclusion, re-introduction of PTEN into LNCaP cells did not block basal NF-B activity but significantly inhibited TNF-induced NF-B transcription (Fig. 1A) . These results indicate that constitutive Akt activity alone, due to a loss of PTEN expression, was not enough to stimulate NF-B activity and indicate that cellular stimulation is required for full NF-B activation, which can be blocked by PTEN expression.
RESULTS

The Transcriptional Activity of NF-B Is Inhibited by PTEN-Our laboratory has demonstrated previously
To determine whether the inhibition of NF-B-dependent transcription by PTEN was specific to the ability of PTEN to block PI3K-dependent stimulation of Akt, additional transient reporter gene assays were performed. LNCaP cells were transiently co-transfected with activated forms of Ha-Ras or calmodulin-dependent kinase kinase (CaMKK) in the presence of either PTEN or vector control plasmid. Expression of activated Ha-Ras(V12) in LNCaP cells effectively up-regulated the NF-B-responsive reporter, which was blocked by co-expression of PTEN protein (Fig. 1B) . The expression of CaMKK, which is known to directly activate Akt in a PIP 3 -independent manner (48), induced the transcriptional activity of NF-B. NF-B activation by CaMKK was not significantly blocked by PTEN (Fig. 1B) . These results indicate that PTEN is capable of inhibiting both TNF-and Ras(V12)-induced transcriptional activation of NF-B, presumably through its ability to down-regulate PI3K-induced PIP 3 levels.
To address further whether the ability of PTEN to block TNF-induced NF-B transcription was associated with a downregulation of Akt activity, LNCaP cells were transfected with a plasmid encoding a constitutively active Akt protein (M-Akt). Due to a myristoylation motif, the M-Akt protein constitutively inserts into the cytoplasmic membrane and no longer requires PIP 3 products generated by PI3K for kinase activity. Thus, we would predict that M-Akt would bypass PTEN-mediated effects and would allow TNF-dependent signals to activate NF-B even in the presence of PTEN expression. As shown in Fig. 1C , expression of M-Akt in LNCaP cells stimulated the transcriptional activity of NF-B. These results suggest that the overexpression of M-Akt acts to stimulate NF-B through mechanisms different from endogenous Akt activity normally displayed in LNCaP cells. Regardless, NF-B activity was increased further in M-Akt-transfected cells following stimulation with TNF (Fig. 1C) . Consistent with the data presented in Fig. 1A , PTEN blocked TNF-induced activation of NF-B. However, expression of M-Akt rescued PTEN-mediated suppression of NF-B following TNF addition (Fig. 1C) . The ability of M-Akt to overcome PTEN-mediated effects on TNF-dependent activation of NF-B was not due to disproportionate transgene expression, because Western blot analysis demonstrated appropriate protein expression of PTEN, Akt, and the ␤-galactosidase control in co-transfection experiments (Fig. 1C) . Therefore, expression of a constitutively active Akt mutant overcomes the ability of PTEN to block TNF-induced activation of NF-B. GFP). Adenoviral-mediated gene transfer is extremely efficient in these cells where, at 10 plaque-forming units (pfu) of virus per cell, 100% of cells display transgene expression (data not shown). Nuclear and cytoplasmic extracts were isolated from adenoviral infected cells following the addition of TNF over the time course indicated. As shown in Fig. 2A , cytoplasmic proteins isolated from LNCaP cells infected with Ad-PTEN demonstrated PTEN protein expression, as compared with Ad-GFP-infected control cells. Importantly, ectopic expression of the PTEN protein was functional in LNCaP cells, because lipid phosphatase activity of this tumor suppressor protein significantly down-regulated the level of activated phospho-specific Akt protein (Fig. 2A) . The inability to detect phosphorylated Akt in Ad-PTEN-infected cells was not due to differences in protein loading, because similar levels of total Akt protein were detected when blots were re-analyzed using a pan-Akt antibody ( Fig. 2A) .
To elucidate whether PTEN expression blocks TNF-induced phosphorylation and proteasome-dependent degradation of IB, cytoplasmic extracts were analyzed for the presence of IB␣ protein. As shown in Fig. 2B , TNF-stimulated extracts displayed a loss of IB␣ protein with similar kinetics in both Ad-GFP-and Ad-PTEN-infected LNCaP cells. Moreover, analysis of the p65 subunit of NF-B confirmed that the addition of TNF led to an increase in nuclear accumulation regardless of whether the cells overexpressed the PTEN tumor suppressor gene product (Fig. 2E) . Collectively, these results indicate that PTEN did not inhibit the transcriptional activity of NF-B through a mechanism that blocked IB␣ degradation and nuclear translocation of p65 in LNCaP cells.
Because Akt has been reported to be required for TNFinduced IKK activity (31, 39) , LNCaP cells expressing PTEN were analyzed for IKK activity following TNF stimulation. As shown in Fig. 2C , LNCaP cells expressing PTEN displayed similar TNF-induced IKK activity, as compared with control cells. These results indicate that PTEN expression did not block TNF-induced IKK activity in these cells. Moreover, although LNCaP cells express constitutively active Akt, these cells fail to display constitutive IKK activity.
PTEN has also been reported to negatively regulate NF-B through mechanisms affecting p50 activity (38) . Because p50 activity is regulated predominantly through IKK-dependent phosphorylation and proteolysis of the p105 precursor protein (49 -51), we analyzed whether PTEN blocked p50 activity by -PTEN) at 10 pfu/cell. Twenty four hours following infection, cells were stimulated with TNF (10 ng/ml) over the time course indicated, and nuclear and cytoplasmic proteins were harvested from cells. Western blot analysis was performed using cytoplasmic extracts, and ectopic expression of PTEN was detected. Endogenous Akt activity was assessed using the phosphospecific antibody that detects phospho-Ser-473 on Akt. Total Akt protein levels were detected using a pan-specific antibody. B-E, PTEN expression in LNCaP cells fails to inhibit IKK activity, TNFinduced degradation of IB␣, p105 processing, and nuclear translocation of the p65 protein. B, cytoplasmic extracts (25 g/lane) from Ad-GFP-and Ad-PTEN-infected LNCaP cells were analyzed for IB␣ protein levels following TNF stimulation. Total IB␣ and ␣-tubulin protein levels were detected. C, TNF-stimulated LNCaP cells expressing either GFP or PTEN were analyzed for IKK activity. Whole cell lysates (100 g) were immunoprecipitated with anti-IKK␥ and incubated with GST-IB␣-(1-54) in the presence of [␥-32 P]ATP. Immunoprecipitates and whole cell extracts were analyzed for IKK␥ and PTEN expression, respectively, by Western blot analysis. D, p50 activity was measured as a function of p105 processing in TNF-stimulated LNCaP cells expressing either GFP or PTEN. LNCaP cells were infected with adenovirus, as described above, or treated with the proteasome inhibitor MG132 (20 M) 1 h prior to the addition of TNF for 30 min. Total proteins (50 g/lane) were subjected to SDS-PAGE, and Western blots were analyzed for protein expression. E, cytoplasmic (C) and nuclear (N) extracts were analyzed for TNF-induced nuclear translocation of the p65 subunit of NF-B. F, PTEN fails to block TNF-induced DNA binding of NF-B. Nuclear proteins (8 g/reaction) were incubated with a 32 P-labeled double-stranded oligonucleotide corresponding to the NF-B consensus site located in the MHC class I promoter. DNAprotein complexes were resolved on a non-denaturing polyacrylamide gel. The NF-B-specific complex (composed of p65 and p50) is indicated by an arrow, as is a nonspecific (NS) band, which indicates relatively equal amounts of nuclear extract in each reaction. An asterisk indicates the p50 homodimer. Nuclear extracts isolated from LNCaP cells infected with the Ad-SRIB␣ and then treated with TNF served as a positive control. inhibiting p105 processing in LNCaP cells following TNF stimulation. LNCaP cells did not display significant increases in p105 processing following the addition of TNF (Fig. 2D) . Moreover, p50 levels did not change following the expression of PTEN or following the addition of the proteasome inhibitor MG132 (Fig. 2D) . Consistent with Fig. 2B , PTEN also did not block TNF-induced degradation of IB␣, but degradation was blocked by pretreatment with MG132 (Fig. 2D) . Therefore, in contrast to previous reports (38) , PTEN failed to block TNFinduced NF-B activity through mechanisms involving p50 activation. Collectively, these results are consistent with our findings that PTEN expression in LNCaP cells does not block IKK-dependent IB␣ degradation or p105 processing nor does it affect p65 nuclear translocation following TNF stimulation (Fig. 2, B, D, and E) .
To elucidate whether PTEN expression affected TNF-induced activation of NF-B through mechanisms involving DNA binding, nuclear extracts were analyzed in EMSAs. As shown in Fig. 2F , adenoviral infected LNCaP cells expressing PTEN displayed similar NF-B DNA binding profiles following the addition of TNF, as compared with cells receiving the Ad-GFP control virus. Interestingly, nuclear extracts from LNCaP cells infected with Ad-PTEN displayed slightly elevated DNA binding activity of NF-B at 1 h post-TNF addition, as compared with Ad-GFP-infected cells (Fig. 2F) . As a control, nuclear extracts isolated from LNCaP cells infected with Ad-SRIB␣, encoding a mutated form of IB␣ that cannot be degraded following TNF stimulation, failed to display TNF-induced NF-B activity (Fig. 2F ). Similar amounts of nuclear extracts were analyzed in EMSAs, because the detection of a nonspecific band displayed comparable levels of intensity in all lanes. Moreover, re-analysis of nuclear extracts by EMSA displayed equal levels of Oct-1-DNA binding complexes that served as a loading control (data not shown).
To determine whether the PTEN effects were specific only to LNCaP cells, we analyzed two other human prostate cell lines, PC-3 and DU-145. PC-3 cells contain not only constitutive Akt activity due to the loss of PTEN function (40, 41) but also display constitutive IKK activation, DNA binding, and NF-Bdependent transcription (52) . On the other hand, DU-145 cells express a functional PTEN protein (41) and consequently do not display constitutive Akt activity. In this way, we could determine whether PTEN expression blocked either basal or TNF-induced nuclear translocation in either PC-3 or DU-145 cells. PC-3 and DU-145 were infected with Ad-GFP, Ad-PTEN, or Ad-SRIB␣, and nuclear extracts were harvested following TNF stimulation. Interestingly, expression of PTEN did not block the high basal NF-B DNA binding activity normally observed in PC-3 cells nor did it inhibit TNF-induced increases in NF-B binding, as compared with Ad-GFP-infected control cells (Fig. 3, left panel) . Ectopic expression of PTEN also did not inhibit TNF-induced NF-B nuclear DNA binding activity in DU-145 cells (Fig. 3, right panel) . However, expression of the SR-IB␣ protein blocked basal NF-B DNA binding activity in PC-3 cells and also inhibited TNF-induced NF-B activity in both PC-3 and DU-145 cells (Fig. 3) . The inability of PTEN to block TNF-induced nuclear translocation signals was not due to differences in adenoviral mediated expression of PTEN, because PTEN was effectively expressed in both PC-3 and DU-145 cells, and constitutively active phospho-Akt was downregulated in PC-3 cells (data not shown). We found that TNF weakly stimulated Akt activity in DU-145 cells, and the expression of PTEN or exposure to the PI3K inhibitor, LY294002, blocked TNF-induced NF-B transcriptional activity in transient reporter assays. However, consistent with the data here, LY294002 failed to block TNF-induced nuclear translocation of NF-B in DU-145 cells, as measured by EMSA (data not shown). PTEN did not affect TNF-induced nuclear translocation and DNA binding of NF-B (composed of p65 and p50 heterodimer) in LNCaP, PC-3, or DU-145 cells. Therefore, despite PC-3 cells displaying a loss of p50 homodimer binding (compare Fig. 2F with Fig. 3 ), we predict that this effect could not account for the ability of PTEN to inhibit NF-B-dependent transcriptional activity. Collectively, these results indicate that the expression of PTEN in LNCaP, PC-3, or DU-145 cells failed to block NF-B DNA binding, suggesting that PTEN functions to block NF-B-dependent gene expression through an alternative mechanism.
PTEN Regulates NFB by Repressing the Transactivation Domain of the p65 Subunit-To determine whether PTEN could modulate NF-B by blocking the transactivation function of p65, we utilized a plasmid encoding a Gal4-p65 fusion protein. In this fusion protein, sequences encoding the DNA binding domain of the yeast Gal4 transcription factor have been joined with sequences encoding the transactivation domain I of p65 (43) . Experiments were performed by co-transfecting cells with an expression plasmid encoding Gal4-p65 and with a Gal4-responsive luciferase reporter (Gal4-Luc). In addition to analyzing p65, we also evaluated whether PTEN could modulate the transactivation domain of CREB, a transcription factor known to be directly phosphorylated by Akt (53) , and c-Jun. As shown in Fig. 4A , the transactivation potential of p65, CREB, and c-Jun was increased in LNCaP cells following the addition of TNF. The expression of PTEN blocked the ability of TNF to stimulate the transactivation domain of p65 and CREB (Fig.  4A) . Interestingly, PTEN expression did not inhibit the ability of TNF to stimulate the transactivation domain of c-Jun (Fig.  4A) . These results suggest that PTEN inhibits TNF-induced NF-B activation by blocking the transactivation potential of p65 and that down-regulation of PIP 3 by PTEN expression also modulates CREB transactivation function.
To understand better the signaling pathways by which PTEN inhibits the transactivation potential of p65, we investigated whether active PI3K or Akt proteins could rescue PTENdependent inhibition in response to TNF. As shown in Fig. 4B , the expression of either PI3K or Akt proteins alone was capable of up-regulating the transactivation potential of p65 above vector control plasmid levels in unstimulated LNCaP cells. This effect was further elevated following the addition of TNF (Fig. 4B) . PTEN expression failed to inhibit the ability of constitutively active PI3K to target the transactivation domain of p65 following TNF stimulation (Fig. 4B) . Moreover, PTEN expression was unable to block the synergistic activation induced by M-Akt following TNF stimulation (Fig. 4B) . Therefore, these results suggest that M-Akt can bypass the requirement for PIP 3 activity, although TNF still provides an inducible signal (Fig. 4B) .
Several reports including our own (15, 30, 36) have indicated that IKK participates in targeting the p65 transactivation domain in response to activated Akt. Recently, we have shown (36) that serine residues 529 and 536, located in the transactivation domain of p65 and shown to be targeted by CK II and IKK, respectively, are both required for Akt-induced activation of NF-B. Therefore, although in Fig. 2D we demonstrate that PTEN did not block the ability of IKK to phosphorylate IB␣ following TNF stimulation, additional transfection experiments were performed to determine whether IKK alone was enough to target the transactivation domain of p65 following TNF stimulation. As shown in Fig. 4B , the expression of IKK␤ activated the transactivation domain of p65 in unstimulated LNCaP cells, which was further enhanced following TNF stimulation. PTEN was capable of inhibiting TNF-stimulated LNCaP cells expressing wild-type IKK␤ (Fig. 4B) . These results suggest that in order for TNF to up-regulate the transactivation domain of p65 in LNCaP cells, both Akt and IKK are required. This hypothesis is supported by the observation that co-expression of both M-Akt and IKK␤ strongly activates the p65 transactivation domain, without the need for TNF stimulation (Fig. 4B) . Moreover, this activation could not be inhibited by the expression of PTEN (Fig. 4B) .
To determine whether Akt and IKK are required for TNFdependent signals to target the transactivation potential of the p65 subunit of NF-B, LNCaP cells were co-transfected with Gal4-p65, the Gal4 reporter, and plasmids encoding for various dominant negative proteins. As shown in Fig. 4C, cells express-FIG. 4. PTEN blocks TNF-induced activation of NF-B by modulating the transactivation domain of p65. A, PTEN inhibits the ability of TNF to stimulate the transactivation domain of the p65 subunit of NF-B. LNCaP cells were co-transfected with plasmids encoding the Gal4-p65, Gal4-CREB, or Gal4-cJun fusion proteins and with the 4ϫGal4-Luc reporter. In addition, cells were transfected with either the empty vector control or with an expression vector encoding wild-type PTEN. Eighteen hours following transfection, cells were either left untreated or were stimulated with TNF (10 ng/ml). Eighteen hours following stimulation, cells were harvested, and luciferase activities were analyzed. Data presented represent the mean Ϯ S.D. of three independent experiments. Bottom panel, Western blot analysis of cell extracts demonstrate PTEN and Gal-4 protein expression. B, activated forms of PI3K and Akt proteins overcome the ability of PTEN to block TNF-induced stimulation of the p65 transactivation domain. LNCaP cells were co-transfected with Gal4-p65, Gal4-Luc reporter, and with plasmids encoding activated PI3K, Akt, IKK␤, Akt, and IKK␤ or empty vector control. Additionally, cells were co-transfected with plasmid encoding PTEN or empty vector control. Eighteen hours following transfection cells were either left untreated or were stimulated with TNF (10 ng/ml). Cell extracts were harvested 18 h following the addition of TNF, and equal amounts of protein lysates were assayed for luciferase activity. Data represent the mean Ϯ S.D. of two individual experiments performed in triplicate. C, the ability of TNF to stimulate the p65 transactivation domain is blocked by PTEN and dominant negative forms of PI3K, Akt, and IKK. LNCaP cells were co-transfected with Gal4-p65, Gal4-Luc reporter, and with expression plasmids encoding PTEN, dominant negative (DN) PI3K (⌬p85), Akt(Lys 3 Met), IKK␤ (SS Ͼ Ͼ AA). Eighteen hours following transfection cells were stimulated with TNF, and 18 h following the addition of TNF, cells were harvested, and luciferase activities were determined. Results represent three separate experiments performed in triplicate, and the mean Ϯ S.D. are shown.
ing plasmids encoding PTEN or dominant negative PI3K, Akt, or IKK␤ all blocked the ability of TNF to stimulate the transactivation domain of p65 in LNCaP cells. Similar results were observed in PC-3 cells, where expression of PTEN or dominant negative constructs encoding PI3K, Akt, or IKK␤ inhibited the basal transactivation potential of the p65 subunit. The ability of PTEN to inhibit the p65 transactivation domain was not specific only to TNF, as this effect was also observed for interleukin-1␤ (data not shown). These results indicate that PTEN modulates NF-B transcriptional activity through a mechanism that controls the transactivation function of the p65 subunit and not by inhibiting signals that control nuclear translocation or DNA binding of NF-B.
The Ability of PTEN to Block the Transactivation Potential of the p65 Subunit of NFB Is Associated with a Loss of NF-Bdependent
Gene Expression-Our results suggest that the ability of PTEN to inhibit PIP 3 and down-regulate Akt activity alone is enough to inhibit the transactivation potential of the p65 subunit, which would be predicted to block endogenous NF-B-dependent gene expression (Fig. 4) . To determine whether the expression of PTEN blocked NF-B-dependent gene expression following TNF stimulation, we analyzed the expression of two NF-B regulated genes, NF-B1 and bcl-3 (54, 55) . LNCaP cells were infected with either Ad-PTEN or Ad-GFP control virus, RNAs were isolated, and Northern blot analysis was performed. As shown in Fig. 5 , LNCaP cells infected with control virus displayed an increase in both NF-B1 and bcl-3 transcripts by 2 h, which persisted for 4 h following TNF stimulation. Consistent with the ability of PTEN to block NF-B transcriptional activity in transient reporter assays, LNCaP cells expressing PTEN displayed a significant decrease in both NF-B1 and bcl-3 transcripts (Fig. 5 ). The differences in gene expression were not due to uneven loading of RNAs, because re-analysis of blots for GAPDH displayed equal levels of transcripts (Fig. 5) . These results are consistent with our finding that the ability of PTEN to down-regulate the transactivation domain of p65 following TNF stimulation is associated with a loss of NF-B-dependent gene expression.
PTEN Potentiates TNF-induced Apoptosis-Thus far, we have established that the re-introduction of the PTEN tumor suppressor protein into LNCaP cells affects the ability of these cells to respond to TNF-induced NF-B transcriptional activation. Since it has been well established that TNF-induced activation of NF-B is required to overcome the ability of this cytokine to induce apoptosis (56 -61), we next investigated the effect of PTEN on cellular sensitivity to TNF-induced apoptosis. As shown in Fig. 6 , LNCaP cells became markedly sensitized to TNF-induced apoptosis following Ad-PTEN infection at a dose as low as 10 ng/ml TNF for 24 h, as compared with LNCaP cells infected with the Ad-GFP control. The histone-associated DNA fragments detected using the Cell Death Detection ELISA (Fig. 6) , were also confirmed using standard agarose gel electrophoresis analysis (data not shown). Collectively, these results indicate that ectopic expression of PTEN in LNCaP cells sensitized these cells to TNF-induced apoptosis. This work is consistent with the idea that modulation of NF-B transcriptional activity by the ability of PTEN to down-regulate Akt activity sensitizes the LNCaP cell line to TNF-induced apoptosis.
DISCUSSION
In this report, we demonstrate that the down-regulation of Akt activity by the re-introduction of the PTEN tumor suppressor protein in prostate epithelial cells inhibits the ability of TNF to stimulate NF-B-dependent transcription. The ability of PTEN to block TNF-induced activation of NF-B is dependent on the lipid phosphatase activity of PTEN and on the concomitant down-regulation of Akt activity. In support of this, we found that constitutively active Akt overcame the ability of PTEN to suppress NF-B activation following TNF stimulation. CaMKK, which has been shown to activate Akt through PI3K-independent pathways (48), was capable of activating NF-B even in the presence of PTEN. In our model system, the inhibition of Akt activity by the expression of PTEN did not block TNF-induced IKK activation, IB␣ degradation, p105 processing, p65 nuclear translocation, or DNA binding of NF-B. Rather, cells expressing PTEN displayed equal or even better NF-B DNA binding activities following TNF stimulation, as compared with cells expressing GFP control protein. To determine mechanistically how PTEN-dependent inhibition of Akt blocked the ability of TNF to stimulate NF-B, we evaluated whether PTEN down-regulated the transactivation potential of the p65 subunit of NF-B. We found that PTEN inhibited the ability of TNF to stimulate the transactivation potential of p65, as well as CREB, but not c-Jun. The transactivation potential of p65 following TNF stimulation could be rescued from Total RNAs were isolated, resolved on a formaldehyde gel, and blotted onto nitrocellulose. Gene expression for NF-B1, bcl-3, and GAPDH were determined by analyzing Northern blots with radiolabeled cDNAs corresponding to these genes. Equal amounts of RNA were loaded in each lane because no differences were observed for GAPDH expression. PTEN-dependent repression by re-introducing activated forms of PI3K and Akt or Akt and IKK. The ability of TNF to stimulate the transactivation domain of p65 was not only blocked by PTEN but also by the expression of dominant negative forms of PI3K, Akt, or IKK␤ proteins. These results suggest that all of these signaling molecules are important for full NF-B-dependent transcriptional activity. Modulation of the transactivation function of p65 by PTEN is important for NF-B-dependent transcription, because PTEN blocked TNF-induced up-regulation of NF-B1 and bcl-3 transcripts. Consistent with a previous report (16) that used a PI3K inhibitor, we find that expression of PTEN results in a loss of Akt and NF-B activities and sensitizes LNCaP cells to TNF-induced apoptosis.
During the preparation of this manuscript, two other independent reports were published that address the effect of the PTEN tumor suppressor gene expression on NF-B activation following stimulation by proinflammatory cytokines (38, 39) . The basic conclusion in both of these studies was that PTEN was capable of inhibiting NF-B-dependent gene expression in transient reporter gene assays. However, some major discrepancies exist between our results and the other reported molecular mechanisms by which PTEN inhibited NF-B (38, 39) . In the other studies, it was argued that expression of PTEN, either transiently or stably, results in a loss of NF-B DNA binding potential. Under no circumstances did we observe this effect in any of the cell lines we tested. Rather, as shown in Figs. 2E and 3 , expression of PTEN results in a slight increase in NF-B DNA binding following TNF stimulation. This effect was not specific to TNF, because PTEN also failed to block NF-B-DNA binding activity in LNCaP cells following IL-1␤ stimulation. 2 Koul et al. (38) also indicated that PTEN expression down-regulated the p50:p50 homodimer DNA-binding complex of NF-B. Although we did observe this effect in PC-3 cells, this mechanism did not account for PTEN-dependent inhibition of NF-B activity and was not observed in either LNCaP or DU-145 cells (Fig. 2E and 3) . In contrast, in our model system PTEN did not block TNF-induced DNA binding of the transcriptionally active p65:p50 heterodimer of classical NF-B. Gustin et al. (39) indicated that PTEN expression blocks the ability of the IKK complex to stimulate IB␣ phosphorylation. Our data strongly indicate that this is not the case in LNCaP, PC-3, or DU-145 cells. On the contrary, we observed instead a normal increase in IB␣ phosphorylation and degradation and nuclear translocation of p65 (Fig. 2, B, D , and E and data not shown). Moreover, LNCaP cells expressing PTEN display normal TNF-induced IKK activity, indicating that PTEN does not block the ability of IKK to phosphorylate IB␣ (Fig. 2C) . If PTEN was functioning to inhibit the ability of the IKK complex to phosphorylate IB, then one would predict that PTEN-deficient cells would maintain constitutive Akt phosphorylation and IKK activity and display constitutive NF-B DNA binding. However, these results are not what was observed in LNCaP cells nor what was reported for PTEN null MEF cells (6) . In contrast, cells constitutively expressing active Akt still require a stimulus to induce IB degradation, DNA binding, and NF-B-dependent gene expression. This is supported not only in our study, but also in other recent reports (38, 39) . Our results and the results of others (38) indicate that constitutively active endogenous Akt alone is not enough to activate effectively the IKK-dependent pathways. Conversely, the inhibition of Akt via PTEN is incapable of fully inhibiting IKK activity and IB␣ phosphorylation and degradation (Fig. 2 , B and C) (38) .
The ability of PTEN to block NF-B-dependent gene expression and sensitize cells to TNF-induced apoptosis may allow insight into the use of pharmacological inhibitors of the PI3K pathway to therapeutically treat human tumors that have lost functional PTEN expression. NF-B is known to protect cells from apoptosis by up-regulating target genes that restrict cytochrome c release from the mitochondria and inhibit caspase activation. To date, these NF-B-regulated genes include cIAP-1, cIAP-2, XIAP, Bcl-X L , Al/Bfl-1, Nrl3, IEX-1L, and the recently discovered NDED (61, 62) . Although the down-regulation of PI3K activity has been shown to induce apoptosis that can be rescued by the overexpression of the p65 subunit of NF-B (16), we cannot exclude the possibility that PTEN induces cell death through other mechanisms as well. For example, as we have described here, another pro-survival transcription factor, CREB, is also negatively regulated by PTEN activity. Huang et al. (63) recently reported similar results indicating that PTEN-mediated repression of phosphorylation of CREB at serine 133 was associated with the transcriptional down-regulation of the bcl-2 protooncogene in human prostate cells. Because Akt has been shown recently (64) to provide protection from the TRAIL/Apo-2L pathway by inhibiting BID cleavage, it is possible that the inhibition of Akt via PTEN expression would sensitize prostate cells to similar death pathways initiated by TNF. Moreover, because Bcl-2 and Bcl-X L block TRAIL-induced apoptosis, it could be that a combination of these different signaling events is required to allow PTEN to sensitize prostate cells to apoptotic stimuli.
